Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis. (1st November 1999) - Maini, R N; Taylor, P C; Paleolog, E; Charles, P; Ballara, S; Brennan, F M; Feldmann, M